Surgical AI Startup Anaut Raises Series B Funding to Accelerate Global Expansion

Anaut Inc., a medical technology company specializing in surgical AI, has successfully raised Series B funding. The round was led by Japan Growth Capital Investment Corporation, with participation from the Japan Bank for International Cooperation and other strategic investors. Anaut’s flagship product, EUREKA α, provides real-time visual support for surgeons to enhance safety and precision. The newly raised capital will be utilized to accelerate international regulatory approvals, such as FDA and CE marks, and to establish subsidiaries in the US and Europe to globalize Japanese surgical expertise.